Quadriceps vs. Hamstring Autograft for ACL Rupture
(SQuASH Trial)
Trial Summary
What is the purpose of this trial?
To date, the use of the quadriceps tendon as an autograft option in primary paediatric Anterior Cruciate Ligament (ACL) reconstruction has not been well studied. The 2018 International Olympic Committee (IOC) Consensus Statement now outlines the quadriceps tendon as a possible autograft option. However, no Randomised Control Trial (RCT) has examined the efficacy of the quadriceps tendon autograft in primary paediatric ACL reconstruction compared to the historical "gold-standard" soft-tissue hamstring autograft in this population. In light of its evidence for favourable outcomes in the adult population, and the (albeit limited) evidence showing safety and promise in the paediatric population, clinical equipoise exists for assessing its impact on outcomes in paediatric patients at the index surgery. This is a parallel, international, multi-centre, blinded randomized controlled trial of 352 skeletally-immature (at the time of injury) patients (ages 10-18 years, inclusive) undergoing primary ACL reconstruction to compare the effect of autograft tendon choice (i.e. hamstring versus soft-tissue quadriceps) on the rates of ACL graft failure, return-to-sport, knee function, pain, health-related quality of life and health utility, psychological factors, range of motion and stability, and any other adverse events at 24 months.
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment Quadriceps tendon autograft, Quadriceps tendon autograft, Soft-tissue quadriceps autograft, Soft tissue hamstring autograft, Hamstring tendon autograft, Soft tissue hamstring graft for ACL rupture?
Research shows that both quadriceps and hamstring tendon autografts are effective for ACL reconstruction, with similar clinical and functional outcomes over a 5-year period. Additionally, quadriceps tendon autografts have been found to have a lower re-rupture rate compared to hamstring tendon autografts.12345
Is it safe to use quadriceps or hamstring tendon autografts for ACL reconstruction?
How does the quadriceps tendon autograft treatment for ACL rupture differ from other treatments?
The quadriceps tendon autograft is unique because it may result in lower re-rupture rates compared to the hamstring tendon autograft, and it is increasingly popular for adolescents who cannot use grafts with bone plugs. It also offers a different option for those who have had previous ACL reconstructions with other types of grafts.345910
Research Team
Darren de SA, MD
Principal Investigator
McMaster University
Eligibility Criteria
This trial is for boys and girls aged 10-18 who have had an ACL injury, speak the clinic's language, and can give informed consent. They must have been active in sports before their injury and be suitable for a specific type of knee surgery. Kids with very flexible joints, significant other health issues, or previous knee surgeries aren't eligible.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo ACL reconstruction using either soft-tissue quadriceps or hamstring autografts
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of knee function and return to sport
Long-term follow-up
Continued monitoring of knee function and re-operation rates
Treatment Details
Interventions
- Quadriceps tendon autograft
- Soft tissue hamstring autograft
Quadriceps tendon autograft is already approved in European Union, United States for the following indications:
- Anterior cruciate ligament reconstruction in skeletally immature patients
- Anterior cruciate ligament reconstruction in pediatric patients
Find a Clinic Near You
Who Is Running the Clinical Trial?
McMaster University
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator
Canadian Orthopaedic Foundation
Collaborator
The Physicians' Services Incorporated Foundation
Collaborator